<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03683537</url>
  </required_header>
  <id_info>
    <org_study_id>MKNC 02/2018</org_study_id>
    <nct_id>NCT03683537</nct_id>
  </id_info>
  <brief_title>Association Between Changes of GFAP After Surgery and Postoperative Delayed Cognitive Recovery</brief_title>
  <official_title>Association Between Changes of GFAP After Surgery and Postoperative Delayed Cognitive Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moscow Clinical Scientific Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moscow Clinical Scientific Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of serum level of glial fibrillary acidic protein (GFAP) before surgery (on the
      day of surgery), 24 hours after surgery and on 3 or 4 postoperative day. Neuropsychological
      testing before surgery and on 3 or 4 day after surgery. Investigation of relationship between
      changes of GFAP and scores of neuropsychological tests.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 15, 2018</start_date>
  <completion_date type="Anticipated">September 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in serum GFAP</measure>
    <time_frame>1 year</time_frame>
    <description>GFAP(3) - GFAP (1); GFAP (2) - GFAP (1)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Astrogliosis</condition>
  <condition>Postoperative Cognitive Dysfunction</condition>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Delayed Neurocognitive decline</arm_group_label>
    <description>Patients in whom there is Delayed Neurocognitive Recovery (DNR) after surgery, based on neuropsychological tests or clinically. DNR is defined as follow: 1)decrease of scores of neuropsychological test scores for more than 1 standard deviation (SD) of these tests; 2)clinically - inability of patient to perform test after surgery because of neurocognitive impairment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal postop neurocognitive function</arm_group_label>
    <description>Patients in whom there is no clinical signs of DNR, defined as in previous group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Glial fibrillary acidic protein</intervention_name>
    <description>3 samples of serum are drawn from patients. The 1st Sample of patient serum is drawn before induction into anesthesia. The 2nd is drawn 24 hours after the 1st one. The 3rd sample is drawn on 3 or 4 postoperative day. All samples collected and preserved in the same temperature as required for ELISA.</description>
    <arm_group_label>Delayed Neurocognitive decline</arm_group_label>
    <arm_group_label>Normal postop neurocognitive function</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who undergo surgery in Moscow Clinical Scientific Center
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with different diseases, who require prolonged laparoscopy or open surgery

          -  Age more than 60

          -  ASA I-III

          -  Informed consent to participate in the study

        Exclusion Criteria:

          -  ASA IV-V

          -  Severe neurodegenerative or psychological diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valery Subbotin, Ph.D., M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Moscow Clinical Scintific Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sergey Kamnev, M.D.</last_name>
    <phone>+0079055918462</phone>
    <email>korium1605@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Moscow Clinical Scientific Center</name>
      <address>
        <city>Moscow</city>
        <zip>111123</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergey Kamnev, M.D.</last_name>
      <phone>+0079055918462</phone>
      <email>korium1605@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 20, 2018</study_first_submitted>
  <study_first_submitted_qc>September 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>June 21, 2019</last_update_submitted>
  <last_update_submitted_qc>June 21, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

